title: Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow-up results.
authors.affiliation: Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan. ktobinai@ncc.go.jp
authors.forename: Kensei
authors.initials: K
authors.lastname: Tobinai
authors.forename: Michinori
authors.initials: M
authors.lastname: Ogura
authors.forename: Kuniaki
authors.initials: K
authors.lastname: Itoh
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Kinoshita
authors.forename: Tomomitsu
authors.initials: T
authors.lastname: Hotta
authors.forename: Takashi
authors.initials: T
authors.lastname: Watanabe
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Morishima
authors.forename: Tadahiko
authors.initials: T
authors.lastname: Igarashi
authors.forename: Takashi
authors.initials: T
authors.lastname: Terauchi
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Ohashi